Telephone
61.2.8296.0000
Address
Level 17 9 Castlereagh Street Sydney, New South Wales (NSW) 2000
Description
N/A
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.03
Trade Value (12mth)
AU$1,226.00
1 week
0%
1 month
-3.45%
YTD
12%
1 year
12%
All time high
1.15
EPS 3 yr Growth
-49.800%
EBITDA Margin
-86.20%
Operating Cashflow
-$3m
Free Cash Flow Return
-17.10%
ROIC
-88.10%
Interest Coverage
-9.00
Quick Ratio
0.60
Shares on Issue (Fully Dilluted)
300m
HALO Sector
Healthcare
Next Company Report Date
N/A
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 October 22 |
Appointment of Director
×
Appointment of Director |
31 October 22 |
Q3 2022 Quarterly Update and Appendix 4C
×
Q3 2022 Quarterly Update and Appendix 4C |
31 May 23 |
Results of Meeting
×
Results of Meeting |
31 May 22 |
Results of Meeting
×
Results of Meeting |
31 March 23 |
Full Year Statutory Accounts
×
Full Year Statutory Accounts |
31 March 23 |
Appendix 4G
×
Appendix 4G |
31 March 23 |
Corporate Governance Statement
×
Corporate Governance Statement |
31 January 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 January 22 |
Q4 2021 Quarterly Update and Appendix 4C
×
Q4 2021 Quarterly Update and Appendix 4C |
31 August 23 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
31 August 22 |
Pause in Trading
×
Pause in Trading |
31 August 22 |
Trading Halt
×
Trading Halt |
31 August 22 |
Half Year Accounts & Appendix 4D
×
Half Year Accounts & Appendix 4D |
30 September 22 |
Placement Completion Update
×
Placement Completion Update |
30 November 22 |
Appointment of CFO
×
Appointment of CFO |
30 April 21 |
Annual Report
×
Annual Report |
28 September 22 |
Becoming a substantial holder
×
Becoming a substantial holder |
28 October 22 |
Appointment of Director
×
Appointment of Director |
28 July 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
28 July 22 |
Q2 2022 Quarterly Update and Appendix 4C
×
Q2 2022 Quarterly Update and Appendix 4C |
28 February 23 |
Preliminary Final Report
×
Preliminary Final Report |
28 August 23 |
Epsilon exit from cultivation activities
×
Epsilon exit from cultivation activities |
28 April 23 |
Notice of AGM, Proxy Form and Annual Report to Shareholders
×
Notice of AGM, Proxy Form and Annual Report to Shareholders |
28 April 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
27 November 23 |
Update on Line of Credit
×
Update on Line of Credit |
27 March 23 |
Notification of cessation of securities - EPN
×
Notification of cessation of securities - EPN |
27 June 22 |
Notification regarding unquoted securities - EPN
×
Notification regarding unquoted securities - EPN |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.